This Week in Science

In this week's Science, a Memorial Sloan Kettering Cancer Center-led team reports new insights into the genomic determinants of immune checkpoint inhibitors, a new class of drugs that use a patient's own T cells to attack cancer. Using whole-exome sequencing of non-small cell lung cancers treated with the antibody pembrolizumab, the researcher found higher nonsynonymous mutation burden in tumors was associated with better responses to treatment.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.